occams business research & consultancy · global in vitro fertilization (ivf) & male and...

Occams Business Research &

Consultancy http://www.marketresearch.com/Occams‐Business‐Research‐Consultancy‐v4040/

Publisher Sample

Phone: 800.298.5699 (US) or +1.240.747.3093 or +1.240.747.3093 (Int'l) Hours: Monday - Thursday: 5:30am - 6:30pm EST

Fridays: 5:30am - 5:30pm EST

Email: [email protected] MarketResearch.com

http://www.marketresearch.com/Occams-Business-Research-Consultancy-v4040/

tili

Global In Vitro Fertilization market -2014-2020

Global In Vitro Fertilization (IVF) & Male And Female Fertility Treatment Market, Intra Cytoplasmic Sperm Injection, IVF Market, Medical Devices, DNA & RNA, Industry Overview, Size, Share, Trends And Forecast 2014 - 2020

Global In Vitro Fertilization Market 2014-2020

- 2 -

About Us:

Occams Business Research (Occam’s) is a global provider of consulting and information services

that combine data refining, expert analysis and application-based client focused reports. We are a

team of industry experts and our trademark is; relevant, detailed research reports with

unsurpassed synthesis of data points into decision-making tools for the rapidly growing

marketplace. These allow users to achieve return on investment in a limited time frame. Our

research spans multiple service areas, industry verticals and geographies. We customise reports to

meet your unique requirements and also provide consulting services.

Try us and you will like to be with us always!

We are Different:

As our deliverables are deeply researched, consistent, focused and simply stated

Redefining business research service approach

Comprehensive and well-aligned research methodology

Innovative yet competitive and applied strategies

360 degree approach towards analysis of micro and macro factors

impacting your markets Collaborative efforts to design your winning strategies

Bridging the information gap

Analysis of macro and micro economic trends

Attractive and user friendly documents

Occam’s Razor

Occam's (or Ockham's) Razor is a principle attributed to the 14th century logician and

Franciscan Friar William of Ockham. The principle states that "Entities should not be

multiplied unnecessarily." Choose the simplest theory over a complex one to explain a

phenomenon as it is going to be the most accurate one. We, at Occams, believe in the Occam’s

principle and apply the same to our deliverables so that our clients are not lost in multiple and

complex analysis. We aim to deliver accurate and relevant analysis in a very simple but

comprehensive yet interesting format.


- 3 -

Global In Vitro Fertilization (IVF) & Male And Female Fertility Treatment Market, Intra Cytoplasmic Sperm Injection, IVF Market, Medical Devices, DNA & RNA, Industry Overview, Size, Share, Trends And Forecast 2014 - 2020

1. Executive summary 2. Market overview 2.1. Market definition 2.2. Recent innovations and clinical trials 2.3. Infertility diagnostic trends 2.4. Regulatory framework by geography 2.5. Key buying criteria 2.6. Gap analysis 2.7. Top market analysis 2.8. End user analysis 2.9. Stakeholder analysis and supply chain management 2.10. Key findings 2.11. Strategic Recommendation 3. Market determinants 3.1. Drivers 3.2. Restraints 3.3. Opportunities 3.4. Challenges 4. Male and Female Infertility 4.1. CAUSES 4.2. TYPES 4.3. Ethical issues 5. Market Segmentation 5.1. Male Infertility Market 5.1.1. Male Infertility tests 5.1.1.1. Semen Analysis techniques 5.1.1.1.1. Computer assisted semen analysis (CASA) 5.1.1.1.2. Others 5.1.1.2. DNA fragmentation 5.1.1.3. Hormone evaluation 5.1.1.4. Testicular Biopsy 5.1.2. Male infertility treatment types 5.1.2.1. Surgery 5.1.2.1.1. Vasovasectomy & Vasoepididymostomy (Vasectomy reversal) 5.1.2.1.2. Microsurgical Sperm Aspiration 5.1.2.1.2.1. MESA 5.1.2.1.2.2. TESE 5.1.2.1.3. Varicocele repair 5.1.2.2. Drug & Hormone Therapy 5.1.2.3. Assisted Reproductive Techniques (ART) 5.1.2.3.1. Intrauterine insemination (IUI) 5.1.2.3.2. In vitro fertilization (IVF) 5.1.2.3.3. Intra cytoplasmic sperm injection (ICSI) 5.2. Female infertility 5.2.1. Female infertility test


- 4 -

5.2.1.1. Ovulation Testing 5.2.1.2. Hysterosalpingography 5.2.1.3. Laparoscopy 5.2.1.4. Ovarian reserve testing 5.2.1.5. Others 5.2.2. Female infertility treatment types 5.2.2.1. Surgery 5.2.2.1.1. Assisted reproductive techniques Intrauterine insemination (IUI) 5.2.2.1.2. In vitro fertilization (IVF) 5.2.2.2. Drug and Hormone therapies 6. Competitive Intelligence 6.1. Key Market Strategies 7. Market Share Analysis 8. Geography Analysis 8.1. North America 8.1.1. USA 8.1.2. Canada 8.1.3. RoNA 8.2. Europe 8.2.1. United Kingdom 8.2.2. France 8.2.3. Germany 8.2.4. Italy 8.2.5. Spain 8.2.6. RoE 8.3. Asia Pacific 8.3.1. China 8.3.2. Japan 8.3.3. India 8.3.4. Australia 8.3.5. RoAPAC 8.4. Latin America 8.4.1. Brazil 8.4.2. Mexico 8.4.3. Argentina 8.4.4. RoLA 8.5. RoW 9. Company Profiling 1. Sereno 2. Cooper Surgical Inc. 3. Teva Pharmaceuticals 4. Origio 5. Cook Medical 6. Cadilla Healthcare ltd. 7. Vitrolife AB 8. ASKA 9. Andology 10. Intas 11. Irvine Scientific 12. Mayo clinic


- 5 -

13. Boston fertility 14. Novartis 15. GlaxoSmithkline 16. Organon International 17. Sanofi Avantis 18. Johnson and Johnson List of tables Table1. Global Infertility treatment market by gender. 2013-2020 (in $billion) Table2. Worldwide Fertility rate (total births per woman) Table3. Global average cost comparison of various treatments Table4. Global Male Infertility treatment market in $million (2013-2020) Table5. Global female Infertility treatment market in $million (2013-2020) Table6. Global Male Infertility Testing Market in $million (2013-2020) Table7. Global CASA Market, 2013-2020 (in $million) Table8. Advantages & Disadvantages of various DNA shearing methods Table8. Global DNA fragmentation market by region, 2013-2020 (in $million) Table9. Global Female infertility testing market, 2013-2020 (in $million) Table10. Ovulation Testing Kits, US prices Table11. Global Ovulation Testing market by region, , 2013-2020 (in $million) Table12. Global Hysterosalpingography market, 2013-2020 (in $million) Table13. Global Laparoscopy market, , 2013-2020 (in $million) Table14. Global market Ovarian reserve testing, 2013-2020 (in $million) Table14. Hormone test cost in the U.S Table15. Global average cost of various infertility treatments Table16. Global Infertility treatment market by Geography in $million (2014-2020) Table17. North America infertility treatment market, 2013-2020 (in $million) Table18. Cost of IVF & ICSI treatment across Canada 2014 Table19. Asia-Pacific infertility treatment market, 2013-2020 (in $million) Table20. Growth rate of the number of IVF clinics in Asia Table21. Europe infertility treatment market, 2013-2020 (in $million) Table22. Average Cost of IVF in Spain Table23. Cost of IVF in Russia List of figures Figure1: Market share of various methods on the total infertility treatment segments, 2013 Figure2: Infertility Drug Market share (%) in 2013 Figure3: Key buying criteria for infertility treatment. Figure4: Cause of infertility based on gender Figure5: Declining fertility rate worldwide Figure6: Number of live births using donor oocyte in the US, (2003-2012) Figure7: Percentage of cycles with elective single embryo transfer in women below 35 years Figure8: Decline in global fertility rate (birth per woman) Figure9: Number of IVF cycles performed in the US. Figure10: US in infertility treatment market, 2013-2020 (in $million Figure11: Canada infertility treatment market, 2013-2020 (in $million) Figure12: China infertility treatment market, 2013-2020 (in $million) Figure13: India infertility treatment market, 2013-2020 ($million) Figure14: Japan infertility treatment market, 2013-2020 ($million) Figure15: South Korea infertility treatment market, 2013-2020 (in $million)


- 6 -

Figure16: Breakdown of foreign patients in South Korea Figure17: Thailand infertility treatment market, 2013-2020 (in $million Figure18: Fertility rate in Europe (2013) Figure19: Italy infertility treatment market, 2013-2020 (in $million) Figure20: France infertility treatment market, 2013-2020 (in $million) Figure21: Germany infertility treatment market, 2013-2020 (in $million) Figure22: Spain infertility treatment market, 2013-2020 (in $million) Figure23: Russia infertility treatment market, 2013-2020 (in $million)

According to W.H.O one in every four couples in developing countries is affected by infertility.

However, it is difficult to address a standard rate of infertility, due to difference in factors in both

males & females. The statistics of infertility show that about 15 to 20 percent of couples face the

problem of infertility in the developed countries. In the developing countries the prevalence is

variable, it is as high as 30% in Sub Saharan Africa to as low as 5 % in China. One of the major

reasons for increasing number of infertility is changing lifestyle in developed countries. Delayed

pregnancies are one of the major reasons in increasing fertility in women. However, in certain

cases, causes of infertility are congenital. The demand for infertility treatment has increased in

developed economies due to reducing reproduction capacity. To maintain the current population

growth average rate of 2.1 children per female is required.

The IVF and male & female infertility market is segmented on the basis of male and female

infertility. It is further classified on the basis of diagnostics tests and treatments for both male &

female infertility.

Male Infertility tests

Semen Analysis techniques

•Computer assisted semen analysis (CASA)

•Others

DNA fragmentation

Hormone evaluation

Testicular Biopsy

Female infertility tests

Ovulation Testing

Hysterosalpingography

Laparoscopy

Ovarian reserve testing

Others


- 7 -

The global male infertility market is driven by the various causes of infertility in males which

includes all medical, environmental and lifestyle causes. Moreover, significant development in

various Assisted Reproductive Technologies (ARTs) such as IVF, GIFT and ZIFT to cure

infertility in males are another reason driving the market growth.

Male infertility treatment types

Surgery

Vasovasectomy & Vasoepididymostomy (Vasectomy reversal)

Microsurgical Sperm Aspiration

MESA TESEVaricocele

repair

Assisted Reproductive Techniques (ART)

Intrauterine

insemination (IUI)

In vitro fertilizatio

n (IVF)

Intra cytoplasmic

sperm injection

(ICSI)

Drug & Hormone Therapy

Female infertility treatment types

Surgery

Assisted reproductive techniques Intrauterine

insemination (IUI)

In vitro fertilization (IVF)

Drug and Hormone therapies


- 8 -

IVF treatment market is on a growth path. The global market that is valued at $10 billion is all

set to double in this decade. A good indication of the potential of the market is fact that private

equity is investing in these companies. The first private equity investment came with ABN Amro

purchasing more than 50 % shares of Monash IVF. In 2010 Monash was the largest provider of

IVF in Australia. In 2010 Quadrant Private Equity moved in on IVF Australia paying $32.6

million for what was believed to be a controlling stake in the company. By 2010, it was merged

with Melbourne IVF and the Queensland Fertility Group, creating Virtus Health. In June, Virtus

became the first infertility treatment company in the world to float on the stock market. It is

now worth over $720 million and recently reported a profit of $27.3 million in 2012-13.

Emerging economies of Asia Pacific provides lucrative opportunities for all such investors who

are seeking a good return on their investment. The markets such as India, Thailand and Russia

are seeing a surge in the number of couples coming down for availing treatment for Infertility.

These are evolving at a higher pace than the markets in USA and Europe. Moreover in countries

like Indonesia and Japan the situation of an aging labour force has surged the demand of IVF,

thus providing an opportunity for creating centres to cater to the increasing demand.

occams business research & consultancy · global in vitro fertilization (ivf) & male and...

Documents